a public good project by the
Synthesis
Company
of California

© 2026

Masato Takahashi | doi.page

0 works0 citations0 h-index

Masato Takahashi

Ibaraki Prefectural University of Health Sciences(JP)Hokkaido University Hospital(JP)

Publications by Year

Research Areas

HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Advanced Breast Cancer Therapies, Kawasaki Disease and Coronary Complications

Most-Cited Works

→ Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association(2017)3,620 cited
→ Pembrolizumab for Early Triple-Negative Breast Cancer(2020)2,940 cited
→ Prevention of Infective Endocarditis(2007)2,785 cited
→ Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer(2019)2,462 cited
→ Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease(2004)1,930 cited
→ Infective Endocarditis(2005)1,699 cited

→ Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association(2004)

1,435 cited

→ The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin(1986)1,406 cited

→ A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome(1991)1,214 cited

→ Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial(2020)594 cited